Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

SOST silencing promotes proliferation and invasion and reduces apoptosis of retinoblastoma cells by activating Wnt/β-catenin signaling pathway

Abstract

This study aimed to investigate the effects of SOST and the Wnt/β-catenin signaling pathway on the proliferation, migration, invasion, and apoptosis of human retinoblastoma cells. Fifty-five retinoblastoma and 21 normal retinal tissue samples were collected as the case group and control group, respectively. HXO-RB44 and SO-RB50 cells were selected and assigned into blank, negative control (NC), siRNA 1, siRNA 2, siRNA 3, IWR-1-endo 1, IWR-1-endo 2 and IWR-1-endo 3 groups. Quantitative real-time polymerase chain reaction (qRT-PCR) was applied to detect the expression of SOST, Wnt-1, and β-catenin in the collected tissue samples. MTT assay, flow cytometry, transwell assay and the starch test were employed to determine the cell proliferation, cell cycle, apoptosis, invasion and migration after transfection. The qRT-PCR and western blotting were also used to detect the mRNA and protein expressions of SOST, Wnt-1, β-catenin, C-myc, Cyclin D1, MMP-2 and MMP-9. The tumor formation in nude mice was conducted to evaluate the effects of SOST on the growth of a transplanted tumor. Compared with normal retinal tissues, the retinoblastoma tissues exhibited a downregulation of SOST but an upregulation of Wnt-1 and β-catenin. The proliferation, invasion and migration of HXO-RB44 and SO-RB50 cells in the SOST-siRNA group were significantly higher than the cells in the blank and NC groups. The expressions of Wnt-1, β-catenin, C-myc, Cyclin D1, MMP-2 and MMP-9 in the three SOST-siRNA groups were elevated, but the SOST decreased when compared with the blank and NC groups. SOST silencing promoted the growth of transplanted tumors in nude mice. These findings indicate that SOST silencing promotes the proliferation, invasion and migration, and decreases the apoptosis of human retinoblastoma cells by activating the Wnt/β-catenin signaling pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Dean M, Bendfeldt G, Lou H, Giron V, Garrido C, Valverde P et al. Increased incidence and disparity of diagnosis of retinoblastoma patients in Guatemala. Cancer Lett 2014; 351: p 59–63.

    Article  CAS  Google Scholar 

  2. Zhang Y, Xue C, Cui H, Huang Z . High expression of TAZ indicates a poor prognosis in retinoblastoma. Diagn Pathol 2015; 10: 187.

    Article  CAS  Google Scholar 

  3. Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS et al. Retinoblastoma. Lancet 2012; 379: 1436–1446.

    Article  Google Scholar 

  4. Wang XQ, Wang YC, Guo YT, Tang X . Effect of piperlongumine on drug resistance reversal in human retinoblastoma HXO-RB44/VCR and SO-Rb50/CBP cell lines. Int J Clin Exp Pathol 2015; 8: 2525–2534.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Shields CL, Lally SE, Leahey AM, Jabbour PM, Caywood EH, Schwendeman R et al. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Curr Opin Ophthalmol 2014; 25: 374–385.

    Article  Google Scholar 

  6. Gao Y, Lu X . Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/beta-catenin pathway. Tumour Biol 2016; 37: 1461–1469.

    Article  CAS  Google Scholar 

  7. Semenov M, Tamai K, He X . SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 2005; 280: 26770–26775.

    Article  CAS  Google Scholar 

  8. Piec I, Washbourne C, Tang J, Fisher E, Greeves J, Jackson S et al. How accurate is your sclerostin measurement? comparison between three commercially available sclerostin ELISA Kits. Calcif Tissue Int 2016; 98: p 546–555.

    Article  CAS  Google Scholar 

  9. Bao X, Liu Y, Han G, Zuo Z, Hu M . The effect on proliferation and differentiation of cementoblast by using sclerostin as inhibitor. Int J Mol Sci 2013; 14: 21140–21152.

    Article  Google Scholar 

  10. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 2001; 68: 577–589.

    Article  CAS  Google Scholar 

  11. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 2001; 10: 537–543.

    Article  CAS  Google Scholar 

  12. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005; 280: 19883–19887.

    Article  CAS  Google Scholar 

  13. Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW et al. Small molecule-mediated disruption of wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 2009; 5: 100–107.

    Article  CAS  Google Scholar 

  14. Wang Y, Sang A, Zhu M, Zhang G, Guan H, Ji M et al. Tissue factor induces vegf expression via activation of the wnt/beta-catenin signaling pathway in arpe-19 cells. Mol Vis 2016; 22: 886–897.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Kivela T . The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 2009; 93: 1129–1131.

    Article  Google Scholar 

  16. Schundeln MM, Hauffa PK, Bauer JJ, Temming P, Sauerwein W, Biewald E et al. Pediatric survivors of retinoblastoma are at risk for altered bone metabolism after chemotherapy treatment early in life. Pediatr Hematol Oncol 2015; 32: 455–466.

    Article  Google Scholar 

  17. Khosravi A, Shahrabi S, Shahjahani M, Saki. N . The bone marrow metastasis niche in retinoblastoma. Cell Oncol 2015; 38: 253–263.

    Article  CAS  Google Scholar 

  18. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001; 107: 513–523.

    Article  CAS  Google Scholar 

  19. Balemans W, Piters E, Cleiren E, Ai M, Van Wesenbeeck L, Warman ML et al. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations. Calcif Tissue Int 2008; 82: 445–453.

    Article  CAS  Google Scholar 

  20. Parisi T, Bronson RT, Lees JA . Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer. Oncogene 2015; 34: 5890–5899.

    Article  CAS  Google Scholar 

  21. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014; 505: 495–501.

    Article  CAS  Google Scholar 

  22. Basolo F, Caligo MA, Pinchera A, Fedeli F, Baldanzi A, Miccoli P et al. Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. Thyroid 2000; 10: 741–746.

    Article  CAS  Google Scholar 

  23. Waas ET, Wobbes T, Lomme RM, DeGroot J, Ruers T, Hendriks T . Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 2003; 90: 1556–1564.

    Article  CAS  Google Scholar 

  24. Zhang L, Shi J, Feng J, Klocker H, Lee C, Zhang J . Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Prostate Cancer Prostatic Dis 2004; 7: 327–332.

    Article  Google Scholar 

  25. Long H, Zhou B, Jiang FG . Expression of MMP-2 and MMP-9 in retinoblastoma and their significance. Int J Ophthalmol 2011; 4: 489–491.

    PubMed  PubMed Central  Google Scholar 

  26. Ghassemi F, Chams H, Sabour S, Karkhaneh R, Farzbod F, Khodaparast M et al. Characteristics of germline and non-germline retinoblastomas. J Ophthalmic Vis Res 2014; 9: 188–194.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We give our sincere appreciation to the reviewers for their helpful comments on this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F-Y Sun.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, T., Wang, LN., Tang, DR. et al. SOST silencing promotes proliferation and invasion and reduces apoptosis of retinoblastoma cells by activating Wnt/β-catenin signaling pathway. Gene Ther 24, 399–407 (2017). https://doi.org/10.1038/gt.2017.31

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2017.31

This article is cited by

Search

Quick links